Metro Healthcare (Indonesia) Performance
| CARE Stock | IDR 171.00 2.00 1.18% |
Metro Healthcare holds a performance score of 27 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.0803, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Metro Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Metro Healthcare is expected to be smaller as well. Use Metro Healthcare Ind total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to analyze future returns on Metro Healthcare Ind.
Risk-Adjusted Performance
27 of 100
Weak | Strong |
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Metro Healthcare Indonesia are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Metro Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 525.5 B | |
| Total Cashflows From Investing Activities | -760.3 B |
Metro |
Metro Healthcare Relative Risk vs. Return Landscape
If you would invest 8,400 in Metro Healthcare Indonesia on September 1, 2024 and sell it today you would earn a total of 8,700 from holding Metro Healthcare Indonesia or generate 103.57% return on investment over 90 days. Metro Healthcare Indonesia is generating 1.1877% of daily returns and assumes 3.3507% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Metro, and 77% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Metro Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Metro Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Metro Healthcare Indonesia, and traders can use it to determine the average amount a Metro Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3545
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CARE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.35 actual daily | 29 71% of assets are more volatile |
Expected Return
| 1.19 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.35 actual daily | 27 73% of assets perform better |
Based on monthly moving average Metro Healthcare is performing at about 27% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Metro Healthcare by adding it to a well-diversified portfolio.
Metro Healthcare Fundamentals Growth
Metro Stock prices reflect investors' perceptions of the future prospects and financial health of Metro Healthcare, and Metro Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Metro Stock performance.
| Return On Equity | -0.0284 | |||
| Return On Asset | -0.0089 | |||
| Profit Margin | (0.40) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 14.97 T | |||
| Shares Outstanding | 33.25 B | |||
| Price To Book | 4.73 X | |||
| Price To Sales | 64.43 X | |||
| Revenue | 290.93 B | |||
| EBITDA | 31.94 B | |||
| Cash And Equivalents | 1.22 T | |||
| Cash Per Share | 36.68 X | |||
| Total Debt | 177.46 B | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 96.76 X | |||
| Cash Flow From Operations | 47.13 B | |||
| Earnings Per Share | 0.67 X | |||
| Total Asset | 4.21 T | |||
About Metro Healthcare Performance
By examining Metro Healthcare's fundamental ratios, stakeholders can obtain critical insights into Metro Healthcare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Metro Healthcare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali. Metro Healthcare operates under Medical Care Facilities classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 9 people.Things to note about Metro Healthcare Ind performance evaluation
Checking the ongoing alerts about Metro Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Metro Healthcare Ind help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Metro Healthcare Ind appears to be risky and price may revert if volatility continues | |
| About 58.0% of the company shares are held by company insiders |
- Analyzing Metro Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Metro Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Metro Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Metro Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Metro Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Metro Healthcare's stock. These opinions can provide insight into Metro Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Metro Stock
Metro Healthcare financial ratios help investors to determine whether Metro Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metro with respect to the benefits of owning Metro Healthcare security.